DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Dahlöf B, Devereux RB, Kjeldsen SE. et al.
Cardiovascular morbidity
and mortality in the Losartan Intervention For Endpoint reduction
in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002; 359 (9311) 995-1003
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.